Mobiis Co., Ltd. (KOSDAQ:250060)
South Korea · Delayed Price · Currency is KRW 2,805.00
-25.00 (-0.88%)
At close: Aug 7, 2026
Mobiis Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Revenue Revenue Growth | 16,888 | 19,082 | 19,665 | 15,214 | 13,892 | 12,236 |
Revenue Growth | -21.70% | -2.96% | 29.25% | 9.52% | 13.53% | 390.12% |
Gross Profit Gross Profit Growth | 2,429 | 3,624 | 4,911 | 7,335 | 7,239 | 4,620 |
Operating Income Operating Income Growth | -7,421 | -6,566 | -4,015 | -1,332 | -393.2 | -1,774 |
Net Income Net Income Growth | 28.6 | -384.78 | -5,759 | -2,237 | -1,443 | -671.95 |
Earnings Per Share EPS Growth | 0.89 | -12.05 | -181.41 | -72.00 | -46.24 | -21.53 |
EPS Growth | - | - | - | - | - | - |
| Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Nuclear Fusion Nuclear Fusion Growth | 2,452 | 1,465 | 1,236 | 771.87 | 2,030 |
Clinical Bio, Etc. Clinical Bio, Etc. Growth | 13,639 | 14,883 | 13,978 | 13,120 | 10,206 |
Smart Factory Smart Factory Growth | 2,991 | 3,318 | - | - | - |
Total Total Growth | 19,082 | 19,665 | 15,214 | 13,892 | 12,236 |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Investments Cash & Investments Growth | 30,999 | 25,332 | 45,508 | 45,190 | 20,905 | 14,725 |
Total Debt Total Debt Growth | 888.22 | 744.74 | 10,288 | 8,862 | 4,466 | 2,344 |
Net Cash (Debt) Net Cash Growth | 30,111 | 24,587 | 35,220 | 36,328 | 16,439 | 12,381 |
Net Cash Growth | -9.51% | -30.19% | -3.05% | 120.98% | 32.77% | -0.04% |
Net Cash Per Share Net Cash Per Share Growth | 940.33 | 769.75 | 1109.43 | 1163.85 | 526.67 | 396.66 |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Operating Cash Flow Operating Cash Flow Growth | -4,668 | -4,800 | -2,096 | -1,458 | 2,457 | -606.06 |
Capital Expenditures CapEx Growth | -398.2 | -655.03 | -1,517 | -1,075 | -93.78 | -102.42 |
Free Cash Flow Free Cash Flow Growth | -5,067 | -5,455 | -3,612 | -2,533 | 2,363 | -708.47 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '24 Mar 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Gross Margin | 14.38% | 18.99% | 24.98% | 48.21% | 52.11% | 37.76% |
Operating Margin | -43.94% | -34.41% | -20.42% | -8.76% | -2.83% | -14.50% |
Pretax Margin | -37.61% | -31.44% | -31.06% | -8.23% | 9.62% | -4.41% |
Profit Margin | 0.17% | -2.02% | -29.29% | -14.70% | -10.39% | -5.49% |
FCF Margin | -30.00% | -28.59% | -18.37% | -16.65% | 17.01% | -5.79% |
| Fiscal Year | Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 10, 2026 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
P/FCF Ratio | - | - | - | - | 33.61 | - |
PS Ratio | 5.31 | 7.28 | 2.60 | 4.76 | 5.72 | 5.98 |